Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

The Hong Kong Polytechnic University

Home Clinical Trial Sponsors and OrganizationsThe Hong Kong Polytechnic University

The Hong Kong Polytechnic University

ACTIVE

Hong Kong Polytechnic University, 香港, 香港特别行政区, Hong Kong, Chinawww.polyu.edu.hkPrivate1,001–5,000 employeesEstablished: 1937-01-01

Also known as:

school of design of the hong kong polytechnic university

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

668

138 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1937

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

596

89.2%

Phase 1

10

1.5%

Phase 2

7

1.1%

Unknown

5

0.8%

Phase 3

1

0.1%

Phase 4

1

0.1%

Trial Status Distribution

Active, not recruiting

26

3.9%

Completed

293

43.9%

Enrolling By Invitation

6

0.9%

Not yet recruiting

106

15.9%

Recruiting

155

23.2%

Suspended

2

0.3%

Terminated

5

0.8%

Unknown

74

11.1%

Withdrawn

1

0.1%

Clinical Trials

Trials sponsored by this organization (668)

A Digitally Supported Outdoor Physical Activity Intervention for Mildly Frail Older Adults in Hong Kong

Not yet recruiting

Feb 2027240 participants

Immersive Gamified Virtual Reality-Based Training for Children With Attention Deficit Hyperactivity Disorder

Not yet recruiting

Jan 2027120 participants

Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis

Not yet recruiting

Jan 2027240 participants

Dyadic Physical Activity Intervention for Children Undergoing Cancer Treatment

Not yet recruiting

Jan 2027198 participants

Effectiveness of A Multi-Component Self-Management Intervention for Anxiety and Respiratory-Related Symptoms in Patients With Lung Cancer

Not yet recruiting

Jan 2027189 participants

Optimizing Implementation of the Intensive Diabetes Prevention Program

Not yet recruiting

Dec 2026170 participants

Strengthening the Ear-to-brain Connection in Older Adults With Hearing Loss Through Engaging Web-based Gamified Auditory-cognitive Dual-task Training: a Randomized Controlled Trial

Not yet recruiting

Nov 2026164 participants

Musical Training: Promoting Brain Function in Children Who Have Survived Brain Tumours

Not yet recruiting

Oct 2026236 participants

Page 1 of 84

Approvals

No approval data available

News

PolyU develops AI Virtual Patient Simulation System for precision cancer care

- A research team at The Hong Kong Polytechnic University (PolyU) has developed a patient-centric "AI Virtual Patient Simulation System" based on a continuously updated "digital twin" model. - The system dynamically integrates multimodal data, including genomic data, medical imaging and clinical records, to track condition changes and predict treatment effectiveness in real time. - A novel framework named ViGNet achieved 82.55% discrimination performance in predicting immunotherapy response in non-small cell lung cancer patients. - The technology was shortlisted as a finalist for the 2026 Global Mobile Awards and is advancing toward commercialisation and clinical deployment.

On this page

Overview
Clinical Trials668
Approvals
News1

Back to Organizations